These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3499908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
    Engberding R, Bender F, Gülker H, Specker E, Molinski M.
    Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridil.
    Verdouw PD, Scheffer MG.
    Arzneimittelforschung; 1984 Aug; 34(1):21-5. PubMed ID: 6608356
    [Abstract] [Full Text] [Related]

  • 7. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M, Brinkmann M, Freund U, Piotrowski J, Schieffer M, Velser U.
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hemodynamic and coronary changes induced by various slow-channel inhibitors in chronic coronary insufficiency: nifedipine, verapamil and bepridil].
    Merillon JP, Duffloux MA, Eustigneff T, Pansard Y, Guiomard A, Zygelman M, Aumont MC, Gourgon R.
    Therapie; 1981 Dec; 36(2):123-34. PubMed ID: 6270840
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
    Flammang D, Waynberger M, Jansen FH, Paillet R, Coumel P.
    Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
    Nishinaka Y, Yokota M, Watanabe M, Sobue T, Iwase M, Ukai M, Ando A, Nagata K, Saito H.
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.